Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Brentuximab Vedotin + Pembrolizumab for Advanced Cancers
Recruiting1 awardPhase 2
Eugene, Oregon
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer, including metastatic cancer that has progressed after PD-1 inhibitor treatment. The study will also find out what side effects occur.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.